Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat

被引:35
作者
Newman, John W.
Kaysen, George A.
Hammock, Bruce D.
Shearer, Gregory C.
机构
[1] Univ Calif Davis, Ctr Canc, Dept Nutr, Davis, CA USA
[2] Univ Calif Davis, Ctr Canc, Dept Entomol, Davis, CA USA
[3] Univ Calif Davis, Ctr Canc, Dept Internal Med, Davis, CA USA
[4] No California Hlth Care Syst, Dept Vet Affairs, Mather, CA USA
关键词
hyperlipidemia; metabolic profiling; eicosanoids; octadecanoids; nephrotic syndrome; oxylipin; lipoprotein;
D O I
10.1194/jlr.M700146-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously established that proteinuria alters the apolipoprotein content of lipoproteins. This study was conducted to establish whether proteinuria also alters the concentrations of oxidized lipids within lipoprotein density fractions. To this end, we induced passive Heymann nephritis in Sprague Dawley rats and measured an array of alkaline-stable oxylipids in VLDL, LDL, and HDL particles. Proteinuria increased the total oxylipid amounts in the HDL and VLDL fractions. More importantly, these levels were increased when expressed per unit lipoprotein protein, indicating that the oxidized lipid load per particle was increased. Epoxides and diols increased -2-fold in HDL and -5-fold in VLDL, whereas LDL showed -2-fold decreases. The hydroxyeicosatetraenoic acids and hydroxyoctadecadienoic acids (HODEs) increased >4-fold in HDL and 20-fold in VLDL, whereas LDL showed -2-fold decreases in the HODEs. Therefore, nephrotic syndrome alters the lipoprotein oxylipid composition independently of an increase in total lipoprotein levels. These proteinuria-induced changes may be associated with the cardiovascular risk of lipoprotein oxidation.
引用
收藏
页码:1792 / 1800
页数:9
相关论文
共 48 条
[11]   Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression [J].
Johnson, ACM ;
Yabu, JM ;
Hanson, S ;
Shah, VO ;
Zager, RA .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) :283-291
[12]  
Kamanna VS, 1996, LAB INVEST, V74, P1067
[13]   APOLIPOPROTEIN AI LEVELS ARE INCREASED IN PART AS A CONSEQUENCE OF REDUCED CATABOLISM IN NEPHROTIC RATS [J].
KAYSEN, GA ;
HOYE, E ;
JONES, H .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 268 (03) :F532-F540
[14]   Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host [J].
Khovidhunkit, W ;
Kim, MS ;
Memon, RA ;
Shigenaga, JK ;
Moser, AH ;
Feingold, KR ;
Grunfeld, C .
JOURNAL OF LIPID RESEARCH, 2004, 45 (07) :1169-1196
[15]   PREPARATION AND THE STRUCTURAL DETERMINATION OF HYDROPEROXY DERIVATIVES OF DOCOSAHEXAENOIC ACID AND OTHER POLYUNSATURATES BY THERMOSPRAY LC MS [J].
KIM, HY ;
SALEM, N .
PROSTAGLANDINS, 1989, 37 (01) :105-119
[16]   Acquired VLDL receptor deficiency in experimental nephrosis [J].
Liang, KH ;
Vaziri, ND .
KIDNEY INTERNATIONAL, 1997, 51 (06) :1761-1765
[17]   Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome [J].
Liang, KH ;
Vaziri, ND .
KIDNEY INTERNATIONAL, 1999, 56 (02) :621-626
[18]   Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice [J].
Luria, Ayala ;
Weldon, Steven M. ;
Kabcenell, Alisa K. ;
Ingraham, Richard H. ;
Matera, Damian ;
Jiang, Huiping ;
Gill, Rajan ;
Morisseau, Christophe ;
Newman, John W. ;
Hammock, Bruce D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (05) :2891-2898
[19]   The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis [J].
Mallat, Z ;
Nakamura, T ;
Ohan, J ;
Lesèche, G ;
Tedgui, A ;
Maclouf, J ;
Murphy, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :421-427
[20]   Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin [J].
Matsumoto, T ;
Takashima, H ;
Ohira, N ;
Tarutani, Y ;
Yasuda, Y ;
Yamane, T ;
Matsuo, S ;
Horie, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (02) :451-457